← boothcheck All Stocks

ABEV

AMBEV S.A.

AMBEV S.A. (ABEV) has a dated report snapshot, but its current priced-in claim is temporarily suppressed because the live engine record is unavailable or has changed.

Live priced in
temporarily suppressed
Priced In
within-range

Key Takeaways

- At about $3.12 the stock trades near 10 times operating income, low enough that the price sits below what even a modest annual decline in operating profit would warrant. This is a value-and-asset-supported name, not a growth bet, and most valuation methods cluster around $2 to $5. - The business is high-return and cash-rich: return on invested capital above 22%, return on equity around 18%, and a net cash position of roughly $3.3 billion. Ambev does not carry the leverage that usually makes an

View Full Report →

Is ABEV overvalued? See what's priced in →

Institutional ownership

396 institutional managers reported holding ABEV in 13F filings for the quarter ended 2026-03-31. Together they hold about 7% of the company; the top 10 hold 5%. 63 opened new positions that quarter. Held by First Eagle Investment Management, GQG Partners, BlackRock, among others. On the short side, 137.8M shares were sold short as of the 2026-06-15 count, about 0.9% of shares outstanding (5.4 days of typical volume to cover).

Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.

Capital returns

ABEV has cut its share count 0.8% over the past five years. It pays a dividend. Cash returned over the past three years: $106.65M in dividends.

Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.

Insider activity

No open-market insider buys on file at ABEV over the trailing three years. Absence is a fact about the company, not a signal. 13 officers and directors are on file.

Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.

Compare ABEV

ABEV vs ADMABEV vs BTIABEV vs BUDABEV vs CCEPABEV vs DEOABEV vs HSY

Last analyzed: June 27, 2026

For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.